Drugs
By Jeffry Fawcett, December 21, 2004 in the Editorials blog
More bad news today for drug companies. It couldn’t happen to a bunch of nicer guys.
Today’s front page continue the bad press about nonsteroidal anti-inflammatory drugs. It started with Vioxx, then came Celebrex, and today Naproxen, the active ingredient in the over-the-counter drug Aleve. [Read more…]